Medicare Enrolled
Dr. Kristen Wendell, DO
Hematology & Oncology · Niles, IL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Wendell from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Wendell?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Wendell
Dr. Kristen Wendell is a hematology & oncology specialist in Niles, IL, with 13 years of NPI registration. Based on federal Medicare data, Dr. Wendell performed 11,125 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Wendell received a total of $3,612 from 39 pharmaceutical and/or device companies across 109 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Wendell is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 13 years of NPI registration
▲ Top 33% volume in IL
$3,612 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗11,125
Medicare services
Top 33% in IL for hematology & oncology
Not available
Unique patients (not deduplicated)
$13
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
4,350 | $0 | $6 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
2,401 | $0 | $3 |
| Denosumab injection (Prolia/Xgeva) | 2,280 | $18 | $67 |
| Anti-nausea injection (Aloxi/palonosetron) | 470 | $1 | $114 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
460 | $0 | $1 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
157 | $12 | $105 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
153 | $64 | $168 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
138 | $148 | $325 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
95 | $99 | $231 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
84 | $102 | $686 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
71 | $11 | $93 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
67 | $99 | $232 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
58 | $6 | $431 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
51 | $143 | $412 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
50 | $66 | $157 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
49 | $22 | $152 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
28 | $23 | $156 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
28 | $1 | $7 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
27 | $49 | $304 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
24 | $51 | $806 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
19 | $155 | $1,055 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 18 | $396 | $1,200 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
16 | $1,212 | $3,637 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
16 | $129 | $354 |
| New patient office visit, complex (60-74 min) | 15 | $184 | $432 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
1.4% high complexity
93.1% medium
5.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$3,612
Total received (2018-2024)
Avg $516/year across 7 years
Top 48% in IL for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
39
Companies
109
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$763
2023
$395
2022
$635
2021
$1,234
2020
$191
2019
$168
2018
$227
Payments by company (2024)
Endomagnetics Ltd
$227
Gilead Sciences, Inc.
$111
Novartis Pharmaceuticals Corporation
$86
Merck Sharp & Dohme LLC
$76
E.R. Squibb & Sons, L.L.C.
$53
TerSera Therapeutics LLC
$36
Fresenius Kabi USA, LLC
$35
AstraZeneca Pharmaceuticals LP
$30
Eisai Inc.
$25
ARRAY BIOPHARMA INC
$24
Mirati Therapeutics, Inc.
$23
ABBVIE INC.
$22
SOBI, INC
$17
Top 3 companies account for 55.5% of 2024 payments
All-time payments by company (2018-2024) ›
Seagen Inc.
$1,032
Novartis Pharmaceuticals Corporation
$401
Endomagnetics Ltd
$227
Gilead Sciences, Inc.
$221
Astellas Pharma US Inc
$208
Takeda Pharmaceuticals U.S.A., Inc.
$132
E.R. Squibb & Sons, L.L.C.
$109
PFIZER INC.
$109
Alexion Pharmaceuticals, Inc.
$99
AstraZeneca Pharmaceuticals LP
$92
Pharmacyclics LLC, An AbbVie Company
$91
Merck Sharp & Dohme LLC
$76
GENZYME CORPORATION
$68
Eisai Inc.
$51
ABBVIE INC.
$51
AbbVie Inc.
$50
GlaxoSmithKline, LLC.
$47
Mirati Therapeutics, Inc.
$44
Novo Nordisk Inc
$38
TerSera Therapeutics LLC
$36
Fresenius Kabi USA, LLC
$35
EMD Serono, Inc.
$33
Regeneron Healthcare Solutions, Inc.
$29
Celgene Corporation
$27
Pharmacyclics LLC, an AbbVie Company
$27
Blueprint Medicines Corporation
$25
ARRAY BIOPHARMA INC
$24
Stemline Therapeutics Inc.
$24
MorphoSys, US Inc.
$23
EISAI INC.
$23
G1 Therapeutics, Inc.
$23
ADC Therapeutics America, Inc.
$22
MACROGENICS, INC.
$21
Amgen Inc.
$20
Merck Sharp & Dohme Corporation
$20
SOBI, INC
$17
Janssen Biotech, Inc.
$15
Daiichi Sankyo Inc.
$12
Verastem, Inc.
$12
Top 3 companies account for 46.0% of all-time payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · ALUNBRIG · AYVAKIT · BOSULIF · Bavencio · CALQUENCE · COSELA · Copiktra · DARZALEX · ENHERTU · EPKINLY · IBRANCE · IMBRUVICA · IMFINZI · KEYTRUDA · KISQALI · KRAZATI · LIBTAYO · LUTATHERA · Lenvima · MARGENZA · MEKINIST · MONJUVI · Magseed · NINLARO · Nplate · OPDIVO · Orserdu · PIQRAY · PROMACTA · Pomalyst · SCEMBLIX · Soliris · Stimufend · TAGRISSO · TASIGNA · TUKYSA · Trodelvy · VENCLEXTA · VONJO · VOTRIENT · Victoza · XALKORI · Xospata · ZEJULA · Zoladex
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
326
County median income
$81,797
Nearest hospital to ZIP centroid (approximate)
ADVOCATE LUTHERAN GENERAL HOSPITAL
2.0 mi
2.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Wendell is a mixed practice specialist, with moderate Medicare volume.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Wendell experienced with anti-nausea injection (fosaprepitant)?
Based on Medicare claims data, Dr. Wendell performed 4,350 anti-nausea injection (fosaprepitant) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Wendell receive payments from pharmaceutical companies?
Yes. Dr. Wendell received a total of $3,612 from 39 companies across 109 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Wendell's costs compare to other hematology & oncology specialists in Niles?
Dr. Wendell's average Medicare payment per service is $13. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Wendell) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Niles
Browse hematology & oncology specialists in Niles ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in IL
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in IL
Which IL hematology & oncology specialists receive the most from drug and device companies.
By company
Seagen Inc. Payments to Doctors
See all physicians who received payments from Seagen Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Endomagnetics Ltd Payments to Doctors
See all physicians who received payments from Endomagnetics Ltd.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology